Jianqiang Li
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Surgical selection and regional lymph node dissection for stage I second primary lung cancer patients following surgery for stage I first primary lung cancer.
Journal: Frontiers in oncology
Published: January 20, 2023
Efficacy of Bevacizumab and Gemcitabine in Combination with Cisplatin in the Treatment of Esophageal Cancer and the Effect on the Incidence of Adverse Reactions.
Journal: BioMed research international
Published: October 18, 2021
The safety and efficacy of neoadjuvant programmed death 1 inhibitor therapy with surgical resection in stage IIIA non-small cell lung cancer.
Journal: Annals of translational medicine
Published: April 14, 2021
Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB-IIIB resectable lung squamous cell carcinoma.
Journal: Journal of thoracic disease
Published: April 12, 2021
The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma.
Journal: Journal of gastrointestinal oncology
Published: March 12, 2021
Neoadjuvant immunotherapy for elderly patients with non-small-cell lung cancer: a case report and literature review.
Journal: Annals of translational medicine
Published: February 11, 2021
Gene Alterations in Paired Supernatants and Precipitates from Malignant Pleural Effusions of Non-Squamous Non-Small Cell Lung Cancer.
Journal: Translational oncology
Published: January 22, 2020
Additional treatment prolonged survival of pulmonary artery sarcoma after surgical resection.
Journal: Translational cancer research
Published: July 25, 2019
Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma.
Journal: OncoTargets and therapy
Published: September 02, 2017
Association between clinicopathological factors and postoperative radiotherapy in patients with completely resected pathological N2 non-small cell lung cancer.
Journal: Oncology letters
Published: December 16, 2016
Positive expression of p53, c-erbB2 and MRP proteins is correlated with survival rates of NSCLC patients.
Journal: Molecular and clinical oncology
Published: July 20, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026